BBC Interview
Ronald DePinho and Jess Mills talk about Baroness Tessa Jowell, the Eliminate Cancer Initiative and the call for the UK to join an international effort to cure brain cancer.
Ronald DePinho and Jess Mills talk about Baroness Tessa Jowell, the Eliminate Cancer Initiative and the call for the UK to join an international effort to cure brain cancer.
Earlier this month, I had the privilege of giving two scientific talks: one at a Grand Rounds lecture hosted by NCI’s Center for Cancer Research, and a second held at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University. Both talks focused on my research and observations on the dynamic interplay between cancer and
The Challenging Landscape of Cancer and Aging: Charting a Way Forward Read More »
A decade ago, Microsoft was considered a dinosaur. It had missed the shift to mobile, was out of step with consumer tastes, and seemed too big and slow to adapt to a digital world that was moving at hyperspeed. Yet today the company is thriving again, largely driven by its growing cloud business. This is
Why the rewards for Ambitious Problem Solving Are About to Get Bigger Read More »
Australians with brain cancer – and all of those who are unknowingly at risk from this nearly always terminal disease – will benefit from an unprecedented initial donation of $10 million by the Minderoo Foundation. The seed funding will be used to develop an innovative “road map” that aims to double survival rates in patients
In a bid to prevent, and compensate, Australian smokers from extreme and unnecessary suffering and death, the Minderoo Foundation, has called on the Federal and State Governments to stop young people from supporting Big Tobacco companies until they are at least 21. The Foundation Chairman and co-founder, Mr Andrew Forrest AO with his wife Nicola,
Legal Action Study underway and calls for Age of Tobacco Purchases to be raised to 21 Read More »
In the last 10 years, remarkable advances have been made in how we fight cancer, work that was made possible by our nation’s support of biomedical research, largely through the National Institutes of Health. One of the most powerful new tools in our arsenal is cancer immunotherapy, which reawakens the body’s own immune system. Immunotherapy
NIH Budget Cuts will Jeopardize American’s Leadership in Medical Research Read More »
A Fordham alumnus who is one of the nation’s luminaries in the field of cancer research will be honored at an alumni event in Washington, D.C., on October 4. Ronald A. DePinho, M.D., FCRH ’77, will receive the Brien McMahon Memorial Award for Distinguished Public Service in recognition of his many contributions to the fight
Alumnus to Be Honored in Washington for Anti-Cancer Efforts Read More »
In this review, we summarize recent work exploring a novel conceptual approach termed “synthetic essentiality” as a means for targeting specific tumor suppressor gene deficiencies in cancer. With the aid of extensive publically available cancer genome and clinical databases, “synthetic essentiality” could be utilized to identify synthetic essential genes, which might be occasionally deleted in
Synthetic Essentiality: Targeting Tumor Suppressor Deficiencies in Cancer Read More »
In the past 10 years, we have made remarkable advances in how we fight cancer. One of the most powerful new tools in our arsenal is cancer immunotherapy, which reawakens our own immune system to produce stunning results for many suffering from advanced cancer. Immunotherapy saved President Jimmy Carter’s life. After being diagnosed with advanced
Making American Research Great Again Read More »
President Donald Trump today announced his intention to appoint Norman “Ned” Sharpless to be the next director of the National Cancer Institute (NCI) in Bethesda, Maryland. Sharpless, who is 50 years old, is a physician and currently director of the Lineberger Comprehensive Cancer Center at the University of North Carolina in Chapel Hill. He also
Trump Names Sharpless to Lead U.S. Cancer Institute Read More »